SG 3 05429
Alternative Names: SG-3-05429Latest Information Update: 19 Jan 2022
At a glance
- Originator Second Genome
- Class Antineoplastics; Immunotherapies; Proteins
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer